Xcell Therapeutics (XKRX:373110) Long-Term Debt : ₩1,132 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Xcell Therapeutics Long-Term Debt?

Xcell Therapeutics's Long-Term Debt for the quarter that ended in Dec. 2024 was ₩1,132 Mil.

Xcell Therapeutics's quarterly Long-Term Debt increased from Jun. 2024 (₩1,046 Mil) to Sep. 2024 (₩1,162 Mil) but then declined from Sep. 2024 (₩1,162 Mil) to Dec. 2024 (₩1,132 Mil).

Xcell Therapeutics's annual Long-Term Debt increased from Dec. 2022 (₩870 Mil) to Dec. 2023 (₩1,148 Mil) but then declined from Dec. 2023 (₩1,148 Mil) to Dec. 2024 (₩1,132 Mil).

Xcell Therapeutics Long-Term Debt Historical Data

The historical data trend for Xcell Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcell Therapeutics Long-Term Debt Chart

Xcell Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

870.00

1,147.50

1,132.44

Xcell Therapeutics Quarterly Data
	Dec19	Dec20	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial							1,147.50	1,075.00	1,045.76	1,161.60	1,132.44

Xcell Therapeutics (XKRX:373110) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Xcell Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Xcell Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Xcell Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xcell Therapeutics Inc (XKRX:373110) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

333, Yeongdong-daero, Gangnam-gu, Seoul, KOR, 06188

Website

http://www.xcell.media

Xcell Therapeutics Inc operates as a research company engaged in development of regenerative medicines. The company is developing proliferation media for various animal cell types.

Xcell Therapeutics Headlines

No Headlines